Skip to content

Sera Prognostics SERA Other intangible assets—net

Other intangible assets—net at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$145.7M-43.4%
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX
Natera, Inc. logo
Natera, Inc.NTRA
Revvity logo
RevvityRVTY
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's other intangible assets—net?
Sera Prognostics (SERA) reported other intangible assets—net of $881K in Q1 2026.
How has Sera Prognostics's other intangible assets—net changed year-over-year?
Sera Prognostics's other intangible assets—net decreased by 11.6% year-over-year, from $997K to $881K.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.